BioWorld MedTech

Dec. 23, 2013

View Archived Issues

Israel's ICI Conference describes major Digital Health 'Apportunity'

FDA/CMS extend parallel review program for two more years

Report from Europe: Baxter receives CE mark for VIVIA HD System

FINANCINGS ROUNDUP: Oracle Investment Management to purchase 12.1M shares of Vermillion

PEOPLE IN PLACES:

PRODUCT BRIEFS:

Keeping you up to date on recent developments in neurology

CFDA streamlines domestic medicaldevice re-registration requirements

Looking to help the domestic device industry continue to grow, China's regulator has issued new regulations for the registration of new products from the beginning of 2014. Read More

Tryton Medical launches its Bifurcation Institute

Today's news in brief

BioWorld

BioWorld briefs for Feb. 14, 2025.

European VCs optimistic for med-tech exit opportunities in 2025

BioWorld MedTech

To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for February 14, 2025

European VCs bullish on med-tech investments in 2025

BioWorld MedTech

European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...

3D illustration of acute myeloid leukemia cells

Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML

BioWorld

Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...